Skip to main content

Search

Reset all filters
342 Result(s)
Sort by

From Idea to Drug

From Idea to Drug

Development of a new drug starts with the hunt for effective compounds and finishes with the approval of the drug. Click here to learn more.
COVID-19 COVID-19 Southeast Asia Donations

COVID-19 COVID-19 Southeast Asia Donations

Beyond direct support of the healthcare community on the ground, several organisations are receiving support in Southeast Asia & South Korea. Learn more.
Spotlight on poultry chicken trends

Spotlight on poultry chicken trends

What’s going on in regional poultry markets around the globe? We asked some of our customers! Click here to find out what they had to say and more.
1885-1948

1885-1948

In 1885, Albert Boehringer purchased a small tartar factory in the Rhine-Hessian village of Nieder-Ingelheim. Click here to learn more about our history.
COVID-19 Q&A for people with diabetes

COVID-19 Q&A for people with diabetes

Here you can find a summary of COVID-19 advice for patients with diabetes. Click here to read the questions and answers to find out more information.
Our Employees

Our Employees

We offer our employees demanding and challenging tasks. Boehringer Ingelheim needs employees who innovate. Learn more about our employees here.
Stroke

Stroke

Boehringer Ingelheim developed the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, now used worldwide.
Data Privacy

Data Privacy

Boehringer Ingelheim International GmbH takes the protection of your personal data seriously. Click here to find out more about data privacy.
Harold Heart and Friends

Harold Heart and Friends

The cardiovascular, renal and metabolic systems are interconnected and dysfunction in one system may lead to dysfunction in the other. Learn more here.
Ethics and Compliance

Ethics and Compliance

Find out about our ethical and compliance standards here. Access and view our Speak Up Policy, EFPIA disclosure, and Supplier Code of Conduct.
COVID-19 Joining forces against COVID-19

COVID-19 Joining forces against COVID-19

While the challenges posed by the COVID-19 pandemic are massive, so are the good examples of corporate citizenship arising all over the world. Learn more.
Boehringer Ingelheim China for a green future

Boehringer Ingelheim China for a green future

Together with all other functions, Fangya Qiang oversees the MORE GREEN programme at Boehringer Ingelheim’s Chinese locations. Click here to learn more.